Montanaro Asset Management Ltd Sells 75 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Montanaro Asset Management Ltd cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 9.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 700 shares of the biotechnology company’s stock after selling 75 shares during the period. Montanaro Asset Management Ltd’s holdings in Axon Enterprise were worth $416,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in AXON. Vanguard Group Inc. increased its holdings in Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after purchasing an additional 275,959 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after buying an additional 35,320 shares during the last quarter. GQG Partners LLC bought a new stake in Axon Enterprise during the fourth quarter worth $478,349,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment bought a new position in Axon Enterprise during the 3rd quarter valued at $200,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on AXON shares. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, The Goldman Sachs Group boosted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Stock Performance

Shares of AXON opened at $559.06 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $42.84 billion, a PE ratio of 144.46, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The stock’s fifty day moving average price is $591.51 and its two-hundred day moving average price is $546.76.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.